- GlaxoSmithKline breaks industry ranks to improve access to medicines
- G20 must put fight against poverty at the center of global economic reforms
- Global leaders must not squander historic opportunity for reform.
- Bold leadership is needed to turn the tide of poverty
- Oxfam in Southern Africa
- Having fought hard for freedom from colonial and racial oppression, millions of rural poor across southern Africa, particularly women, still struggle to overcome social and economic inequality, natural disasters, and disease. They continue to fight for their rights.
- Working together to end poverty and injustice
- An overview of Oxfam America and our approach to poverty relief and lasting social change.
- Ending the R&D Crisis in Public Health
- Investing for Life
- Meeting poor people's needs for access to medicines through responsible business practices
- The World is Still Waiting
- Broken G8 promises are costing millions of lives
- All Costs, No Benefits
- How TRIPS-plus intellectual property rules in the US-Jordan FTA affect access to medicines
- Patents versus Patients
- Five years after the Doha Declaration
- Song of the Sirens
- Why the US–Andean FTAs undermine sustainable development and regional integration
- Public Health at Risk
- A US Free Trade Agreement could threaten access to medicines in Thailand
- Oxfam America Organizing Guide
- Tips for taking action in your community
- Oxfam America House Party Guide
- Tools for hosting a high-impact event
Features Subscribe | View All
A simple guide to patents and trademarks
Patents and trademarks—otherwise known as IP (intellectual property)—and why it is so important for poor countries.
Access to medicines means access to life
During a US tour, Thai activists explain how a trade agreement could limit access to affordable HIV and AIDS drugs.
